Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Clonal Interference of Signaling Mutations Holds Prognostic Relevance in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)

Raphael Itzykson, MD PhD, Nicolas Duployez, PharmD, PhD, Annette Fasan, PhD, Alice Marceau-Renaut, PharmD, Manja Meggendorfer, PhD, Eric Jourdan, MD, Arnaud Petit, MD PhD, Hélène Lapillonne, MD PhD, Jean-Baptiste Micol, MD PhD, Pascale Cornillet-Lefebvre, Norbert Ifrah, MD, Guy Leverger, MD PhD, Herve Dombret, MD, Nicolas Boissel, MD PhD, Torsten Haferlach, MD, Claude Preudhomme, PharmD, PhD

Blood (2017) 130 (Supplement 1): 26.

https://doi.org/10.1182/blood.V130.Suppl_1.26.26

Published: 2017

Journal Articles

Impact of 9q Deletions on the Classification in AML

Bettina Balk, Anna Stengel, PhD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 3925.

https://doi.org/10.1182/blood.V130.Suppl_1.3925.3925

Published: 2017

Journal Articles

In Depth Molecular Characterization of AML with RUNX1-RUNX1T1 at Diagnosis and Relapse

Alexander Höllein, MD, Niroshan Nadarajah, Manja Meggendorfer, PhD, Annette Fasan, PhD, Sabine Jeromin, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 1416.

https://doi.org/10.1182/blood.V130.Suppl_1.1416.1416

Published: 2017

Journal Articles

NPM1 Mutated AML Can Relapse with Wildtype NPM1 and Evolve with Novel Mutations: Implications for Pathobiology and MRD Monitoring

Alexander Höllein, MD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Frank Dicker, PhD, Sabine Jeromin, PhD, Niroshan Nadarajah, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 1417.

https://doi.org/10.1182/blood.V130.Suppl_1.1417.1417

Published: 2017

Journal Articles

Clonal Progression during First Course of Chemotherapy in Acute Myeloid Leukemia Suboptimal Responders Heralds Reinduction Failure and Early Death

Anita Tranberg Simonsen, BSc, MSc, Manja Meggendorfer, PhD, Sarah Koch, Annette Fasan, PhD, Wolfgang Kern, MD, Line Nederby, MSc, PhD, Peter Hokland, MD, Hans Beier Ommen, MD PhD

Blood (2017) 130 (Supplement 1): 1418.

https://doi.org/10.1182/blood.V130.Suppl_1.1418.1418

Published: 2017

Journal Articles

Feasibility of Targeted RNA Sequencing for Routine Diagnostics of B-Cell Precursor ALL

Annette Fasan, PhD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 2711.

https://doi.org/10.1182/blood.V130.Suppl_1.2711.2711

Published: 2017

Journal Articles

Comprehensive Molecular Characterization of Myeloid Malignancies with 9q Deletion

Luise Hartmann, PhD, Torsten Haferlach, MD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Anna Stengel, PhD, Melanie Zenger, Kathleen Zieschang, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 2953.

https://doi.org/10.1182/blood.V130.Suppl_1.2953.2953

Published: 2017

Journal Articles

Correlation of Myelodysplasia-Related Flow Cytometric Findings with Mutations in Patients Undergoing Diagnostics for Suspected Myelodysplastic Syndrome

Wolfgang Kern, MD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 2969.

https://doi.org/10.1182/blood.V130.Suppl_1.2969.2969

Published: 2017

Journal Articles

Molecular Genetics Provides Important Information for Initial Evaluation of Patients with Suspected MDS

Annette Fasan, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD, Wolfgang Kern, MD

Blood (2017) 130 (Supplement 1): 1675.

https://doi.org/10.1182/blood.V130.Suppl_1.1675.1675

Published: 2017

Journal Articles

Deletion 7q Is Associated with KLF2 and NOTCH2 Mutations and Is Strongly Correlated with Splenic Marginal Zone Lymphoma but Also Found in Lymphoplasmacytic Lymphoma and Hairy Cell Leukemia Variant

Alexander Höllein, MD, Anna Stengel, PhD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 1465.

https://doi.org/10.1182/blood.V130.Suppl_1.1465.1465

Published: 2017

Journal Articles

A Comprehensive Panel of Molecular Mutations Notably Improves a Cytogenetic Prognostication System in Routine AML Diagnostics

Claudia Haferlach, MD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Karolina Perglerová, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2016) 128 (22): 286.

https://doi.org/10.1182/blood.V128.22.286.286

Published: 2016

Journal Articles

CSF3R Mutations Are Predominantly Subclonal Events in Intermediate Risk Karyotype AML and Prevalently Occur with CEBPA Mutations

Annette Fasan, PhD, Claudia Haferlach, MD, Karolína Perglerová, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2016) 128 (22): 1658.

https://doi.org/10.1182/blood.V128.22.1658.1658

Published: 2016

Journal Articles

Three Steps to the Diagnosis of Adult Ph-like ALL

Annette Fasan, PhD, Wolfgang Kern, MD, Niroshan Nadarajah, M.Sc., Simone Weber, Sonja Schindela, Nicole Schlenther, Susanne Schnittger, PhD, Torsten Haferlach, Claudia Haferlach, MD

Blood (2015) 126 (23): 2610.

https://doi.org/10.1182/blood.V126.23.2610.2610

Published: 2015

Journal Articles

AML with RUNX1 Mutations and Loss of RUNX1 Wild-Type - a Distinct Subset?

Claudia Haferlach, MD, Niroshan Nadarajah, M.Sc., Annette Fasan, PhD, Karolína Perglerová, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2015) 126 (23): 2578.

https://doi.org/10.1182/blood.V126.23.2578.2578

Published: 2015

Journal Articles

Myeloid Malignancies with Isolated 7q Deletion Can be Further Characterized By Their Accompanying Molecular Mutations

Claudia Haferlach, MD, Annette Fasan, PhD, Manja Meggendorfer, PhD, Melanie Zenger, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 3811.

https://doi.org/10.1182/blood.V126.23.3811.3811

Published: 2015

Journal Articles

Prognosis of Mecom(EVI1)- rearranged MDS and AML Patients Strongly Depends on Accompanying Molecular Mutations but Not on Blast Counts

Tamara Alpermann, Claudia Haferlach, MD, Annette Fasan, PhD, Sonja Schindela, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 1372.

https://doi.org/10.1182/blood.V126.23.1372.1372

Published: 2015

Journal Articles

Clinical Impact of Minimal Residual Disease (MRD) Monitoring in AML with PM - Rara , CBFB - MYH11 , and RUNX1 - RUNX1T1 : A Study on 600 Patients

Torsten Haferlach, Manja Meggendorfer, PhD, Susanne Schnittger, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2015) 126 (23): 228.

https://doi.org/10.1182/blood.V126.23.228.228

Published: 2015

Journal Articles

Landscape of Secondary Genetic Lesions in Acute Myeloid Leukemia with Inv(16)/ CBFB-MYH11

Annette Fasan, PhD, Claudia Haferlach, MD, Karolína Perglerová, Sonja Schindela, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 801.

https://doi.org/10.1182/blood.V126.23.801.801

Published: 2015

Journal Articles

CML Patients with Resistance to Tyrosine Kinase Inhibitors and without BCR-ABL1 Resistance Mutation Frequently Carry Other Gene Mutations

Susanne Schnittger, PhD, Claudia Haferlach, MD, Niroshan Nadarajah, M.Sc., Manja Meggendorfer, PhD, Annette Fasan, PhD, Dominic Rose, PhD, Tamara Alpermann, Wolfgang Kern, MD, Torsten Haferlach

Blood (2014) 124 (21): 4516.

https://doi.org/10.1182/blood.V124.21.4516.4516

Published: 2014

Journal Articles

Complexity of CEBPA Mutated Acute Myeloid Leukemia

Annette Fasan, PhD, Claudia Haferlach, MD, Karolina Perglerová, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2014) 124 (21): 2348.

https://doi.org/10.1182/blood.V124.21.2348.2348

Published: 2014

NARROW

Clonal Interference of Signaling Mutations Holds Prognostic Relevance in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)

Impact of 9q Deletions on the Classification in AML

In Depth Molecular Characterization of AML with RUNX1-RUNX1T1 at Diagnosis and Relapse

NPM1 Mutated AML Can Relapse with Wildtype NPM1 and Evolve with Novel Mutations: Implications for Pathobiology and MRD Monitoring

Clonal Progression during First Course of Chemotherapy in Acute Myeloid Leukemia Suboptimal Responders Heralds Reinduction Failure and Early Death

Feasibility of Targeted RNA Sequencing for Routine Diagnostics of B-Cell Precursor ALL

Comprehensive Molecular Characterization of Myeloid Malignancies with 9q Deletion

Correlation of Myelodysplasia-Related Flow Cytometric Findings with Mutations in Patients Undergoing Diagnostics for Suspected Myelodysplastic Syndrome

Molecular Genetics Provides Important Information for Initial Evaluation of Patients with Suspected MDS

Deletion 7q Is Associated with KLF2 and NOTCH2 Mutations and Is Strongly Correlated with Splenic Marginal Zone Lymphoma but Also Found in Lymphoplasmacytic Lymphoma and Hairy Cell Leukemia Variant

A Comprehensive Panel of Molecular Mutations Notably Improves a Cytogenetic Prognostication System in Routine AML Diagnostics

CSF3R Mutations Are Predominantly Subclonal Events in Intermediate Risk Karyotype AML and Prevalently Occur with CEBPA Mutations

Three Steps to the Diagnosis of Adult Ph-like ALL

AML with RUNX1 Mutations and Loss of RUNX1 Wild-Type - a Distinct Subset?

Myeloid Malignancies with Isolated 7q Deletion Can be Further Characterized By Their Accompanying Molecular Mutations

Prognosis of Mecom(EVI1)- rearranged MDS and AML Patients Strongly Depends on Accompanying Molecular Mutations but Not on Blast Counts

Clinical Impact of Minimal Residual Disease (MRD) Monitoring in AML with PM - Rara , CBFB - MYH11 , and RUNX1 - RUNX1T1 : A Study on 600 Patients

Landscape of Secondary Genetic Lesions in Acute Myeloid Leukemia with Inv(16)/ CBFB-MYH11

CML Patients with Resistance to Tyrosine Kinase Inhibitors and without BCR-ABL1 Resistance Mutation Frequently Carry Other Gene Mutations

Complexity of CEBPA Mutated Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only